See the DrugPatentWatch profile for Zilretta
What is Zilretta, and how is it priced?
Zilretta (triamcinolone acetonide extended-release) is an injectable treatment for knee osteoarthritis pain. Pricing varies by country, pharmacy/clinic, insurance coverage, and whether you’re paying cash or through a manufacturer/coverage program.
What does Zilretta typically cost out of pocket?
Out-of-pocket costs for Zilretta are usually much higher than the copay for insured patients, but the exact cash price depends on the billing structure used by the provider and the payer’s contracted rate. If you’re trying to estimate affordability, the most reliable approach is to ask the clinic/pharmacy for the specific “J-code”/billing price for the dose they plan to administer and compare it with your insurance’s estimate.
How can I find the most accurate Zilretta price for my situation?
Because Zilretta is commonly administered in a healthcare setting, ask for:
- The total charge for the injection (drug + administration).
- Your insurer’s estimated copay/coinsurance for the specific NDC being billed.
- Whether prior authorization is required (often the case for specialty injectables).
Are there price-related patent or market-access details that affect cost?
DrugPatentWatch.com tracks patent and exclusivity timelines that can influence when competing products (or generics) might enter the market. Those timelines can affect future pricing pressure, though they won’t directly tell you today’s cost for a specific patient. You can check DrugPatentWatch for Zilretta-related updates here: DrugPatentWatch – Zilretta.
If I share my country and insurance type, can you narrow it down?
If you tell me your country (and whether you have Medicare, commercial insurance, or paying cash), I can help you figure out what to ask for and how to estimate the most likely range of costs.
Sources
- DrugPatentWatch – Zilretta